We are analyzing https://link.springer.com/article/10.1007/s11910-014-0500-6.

Title:
Tau PET Imaging in Alzheimer’s Disease | Current Neurology and Neuroscience Reports
Description:
In several neurodegenerative diseases that are collectively called tauopathies, progressive accumulation of tau in the brain is closely associated with neurodegeneration and cognitive impairment. Noninvasive detection of tau protein deposits in the brain would be useful to diagnose tauopathies as well as to track and predict disease progression. Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo. For use of tau PET as a biomarker of tau pathology in Alzheimer’s disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-β and other protein deposits. PET tau imaging enables the longitudinal assessment of the spatial pattern of tau deposition and its relation to amyloid-β pathology and neurodegeneration. This technology could also be applied to the pharmacological assessment of anti-tau therapy, thereby allowing preventive interventions.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

pubmed, article, google, scholar, disease, alzheimers, cas, tau, imaging, pet, brain, furumoto, okamura, central, neurofibrillary, amyloid, neurol, pathology, med, harada, dementia, alzheimer, binding, neurosci, plaques, aging, foderotavoletti, nucl, vivo, tangles, japan, content, research, access, preclinical, mulligan, tracer, privacy, cookies, neurology, nobuyuki, kudo, neurodegeneration, protein, deposits, phftau, institute, dement, nat, rev,

Topics {✒️}

pittsburgh compound-b-negative dementia phf-tau radioligand [f18]-t808 month download article/chapter phf-tau radioligand [f-18]-t807 radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives voxel-based morphometry study kazuhiko yanai declare 11c-labeled 6-substituted 2-arylbenzothiazoles fodero-tavoletti mt neuroscience reports aims neurodegenerative diseases alpha-synuclein/lewy bodies article current neurology full article pdf privacy choices/manage cookies hof pr amyloid imaging tracers alzheimer disease therapy–moving clinical amyloid imaging early-stage alzheimer stein td yukitsuka kudo amyloid imaging agents tau pet imaging multitracer pet imaging c-11-labeled radiopharmaceuticals anti-tau therapy molecular imaging insights tau-mediated neurodegeneration tau imaging tracer neurofibrillary tangle type imaging neurofibrillary pathology related immunohistochemical markers small gw tau pet radiotracers fodero-tavoletti european economic area allowing preventive interventions wild-type rodents chronic traumatic encephalopathies chronic traumatic encephalopathy tracking pathophysiological processes sumitomo electric industries nat rev neurol neurofibrillary tangle pathology conditions privacy policy updated hypothetical model article okamura vivo tau imaging 18f-thk5105 pet

Questions {❓}

Tau aggregation in the hippocampal formation: an ageing or a pathological process?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Tau PET Imaging in Alzheimer’s Disease
         description:In several neurodegenerative diseases that are collectively called tauopathies, progressive accumulation of tau in the brain is closely associated with neurodegeneration and cognitive impairment. Noninvasive detection of tau protein deposits in the brain would be useful to diagnose tauopathies as well as to track and predict disease progression. Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo. For use of tau PET as a biomarker of tau pathology in Alzheimer’s disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-β and other protein deposits. PET tau imaging enables the longitudinal assessment of the spatial pattern of tau deposition and its relation to amyloid-β pathology and neurodegeneration. This technology could also be applied to the pharmacological assessment of anti-tau therapy, thereby allowing preventive interventions.
         datePublished:2014-09-21T00:00:00Z
         dateModified:2014-09-21T00:00:00Z
         pageStart:1
         pageEnd:7
         sameAs:https://doi.org/10.1007/s11910-014-0500-6
         keywords:
            Positron emission tomography
            Amyloid
            Tau
            Neurofibrillary tangles
            Dementia
            Early diagnosis
            Biomarker
            Neurology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11910-014-0500-6/MediaObjects/11910_2014_500_Fig1_HTML.gif
         isPartOf:
            name:Current Neurology and Neuroscience Reports
            issn:
               1534-6293
               1528-4042
            volumeNumber:14
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Nobuyuki Okamura
               affiliation:
                     name:Tohoku University School of Medicine
                     address:
                        name:Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
                        type:PostalAddress
                     type:Organization
                     name:Tohoku University
                     address:
                        name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Ryuichi Harada
               affiliation:
                     name:Tohoku University
                     address:
                        name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shozo Furumoto
               affiliation:
                     name:Tohoku University
                     address:
                        name:Frontier Research Institute for Interdisciplinary Science, Tohoku University, Sendai, Japan
                        type:PostalAddress
                     type:Organization
                     name:Tohoku University
                     address:
                        name:Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hiroyuki Arai
               affiliation:
                     name:Tohoku University
                     address:
                        name:Department of Geriatrics and Gerontology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kazuhiko Yanai
               affiliation:
                     name:Tohoku University School of Medicine
                     address:
                        name:Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yukitsuka Kudo
               affiliation:
                     name:Tohoku University
                     address:
                        name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Tau PET Imaging in Alzheimer’s Disease
      description:In several neurodegenerative diseases that are collectively called tauopathies, progressive accumulation of tau in the brain is closely associated with neurodegeneration and cognitive impairment. Noninvasive detection of tau protein deposits in the brain would be useful to diagnose tauopathies as well as to track and predict disease progression. Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo. For use of tau PET as a biomarker of tau pathology in Alzheimer’s disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-β and other protein deposits. PET tau imaging enables the longitudinal assessment of the spatial pattern of tau deposition and its relation to amyloid-β pathology and neurodegeneration. This technology could also be applied to the pharmacological assessment of anti-tau therapy, thereby allowing preventive interventions.
      datePublished:2014-09-21T00:00:00Z
      dateModified:2014-09-21T00:00:00Z
      pageStart:1
      pageEnd:7
      sameAs:https://doi.org/10.1007/s11910-014-0500-6
      keywords:
         Positron emission tomography
         Amyloid
         Tau
         Neurofibrillary tangles
         Dementia
         Early diagnosis
         Biomarker
         Neurology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11910-014-0500-6/MediaObjects/11910_2014_500_Fig1_HTML.gif
      isPartOf:
         name:Current Neurology and Neuroscience Reports
         issn:
            1534-6293
            1528-4042
         volumeNumber:14
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Nobuyuki Okamura
            affiliation:
                  name:Tohoku University School of Medicine
                  address:
                     name:Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
                     type:PostalAddress
                  type:Organization
                  name:Tohoku University
                  address:
                     name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Ryuichi Harada
            affiliation:
                  name:Tohoku University
                  address:
                     name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shozo Furumoto
            affiliation:
                  name:Tohoku University
                  address:
                     name:Frontier Research Institute for Interdisciplinary Science, Tohoku University, Sendai, Japan
                     type:PostalAddress
                  type:Organization
                  name:Tohoku University
                  address:
                     name:Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hiroyuki Arai
            affiliation:
                  name:Tohoku University
                  address:
                     name:Department of Geriatrics and Gerontology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kazuhiko Yanai
            affiliation:
                  name:Tohoku University School of Medicine
                  address:
                     name:Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yukitsuka Kudo
            affiliation:
                  name:Tohoku University
                  address:
                     name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Current Neurology and Neuroscience Reports
      issn:
         1534-6293
         1528-4042
      volumeNumber:14
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Tohoku University School of Medicine
      address:
         name:Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
         type:PostalAddress
      name:Tohoku University
      address:
         name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
         type:PostalAddress
      name:Tohoku University
      address:
         name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
         type:PostalAddress
      name:Tohoku University
      address:
         name:Frontier Research Institute for Interdisciplinary Science, Tohoku University, Sendai, Japan
         type:PostalAddress
      name:Tohoku University
      address:
         name:Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
         type:PostalAddress
      name:Tohoku University
      address:
         name:Department of Geriatrics and Gerontology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
         type:PostalAddress
      name:Tohoku University School of Medicine
      address:
         name:Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
         type:PostalAddress
      name:Tohoku University
      address:
         name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Nobuyuki Okamura
      affiliation:
            name:Tohoku University School of Medicine
            address:
               name:Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
               type:PostalAddress
            type:Organization
            name:Tohoku University
            address:
               name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Ryuichi Harada
      affiliation:
            name:Tohoku University
            address:
               name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
               type:PostalAddress
            type:Organization
      name:Shozo Furumoto
      affiliation:
            name:Tohoku University
            address:
               name:Frontier Research Institute for Interdisciplinary Science, Tohoku University, Sendai, Japan
               type:PostalAddress
            type:Organization
            name:Tohoku University
            address:
               name:Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
               type:PostalAddress
            type:Organization
      name:Hiroyuki Arai
      affiliation:
            name:Tohoku University
            address:
               name:Department of Geriatrics and Gerontology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
               type:PostalAddress
            type:Organization
      name:Kazuhiko Yanai
      affiliation:
            name:Tohoku University School of Medicine
            address:
               name:Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
               type:PostalAddress
            type:Organization
      name:Yukitsuka Kudo
      affiliation:
            name:Tohoku University
            address:
               name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
      name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
      name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
      name:Frontier Research Institute for Interdisciplinary Science, Tohoku University, Sendai, Japan
      name:Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
      name:Department of Geriatrics and Gerontology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
      name:Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
      name:Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(202)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.46s.

LINK . SPRINGER . COM {}